Skip to main content
. 2020 Apr 18;9(8):e015473. doi: 10.1161/JAHA.119.015473

Table 1.

Breakdown of the Original Linkage Studies Demonstrating the Co‐Segregation of Genetic Variants and Hypertrophic Cardiomyopathy in Large Pedigrees and Incontrovertibly Associating Sarcomeric Genes With HCM

Gene Protein Demonstrated Associations Year Reference No. Inheritance N Pedigrees—(Total Size) Max LOD Notes
MYH7 Beta‐myosin heavy chain Locus 14q1 1989 7 AD 1 (96) 9.37 ···
Locus 14q11‐12 1990 8 1 (96) 4.62 ···
Gene 1990 9 1 (96) 15.9 ···
Genetic heterogeneity of HCM 1990 10 4 (173) 10.85 ···
TNNT2 Cardiac troponin T Locus 1q3 1993 11 AD 3 (97) 8.47 ···
Gene 1994 12 1 (70) 6.3 ···
MYBPC3 Myosin‐binding protein C Locus 11p13‐q13 1993 13 AD 1 (54) 4.98 ···
Gene 1995 14 2 (46) 3.74 ···
TPM1 Alpha tropomyosin Locus 15q2 1993 15 AD 2 (87) 6.02 ···
Gene 1994 12 2 (87) 6.94 ···
MYL3 Essential myosin light chain 3 Gene 1996 16 AD 1 (53) 6.2 ···
TNNI3 Cardiac troponin I Gene 1997 17 AD 1 (18) 3.1 ···
MYL2 Regulatory myosin light chain 2 Gene 1998 18 AD 3 (47) 2.41 (estimated) a
ACTC1 Alpha actin (cardiac muscle) 1 Gene 1999 19 AD 1 (22) 3.6 ···

AD indicates autosomal dominant; and HCM, hypertrophic cardiomyopathy.

a

Although an LOD score of 2.41 is below the universally accepted threshold of LOD=3 for co‐segregation to be considered unequivocal, in the years following this original association with HCM, further evidence about the gene's disease‐causing role in HCM gradually accumulated20, 21, 22, and collectively made the association incontrovertible. A larger family with HCM due to a pathogenic variant in MYL2 was reported recently, with a LOD score for co‐segregation of 4.51.23